Vacuum suction body contouring unit CryoSlim® Hybrid

cryolipolysis unittransportable

Overview
The CryoSlim® Hybrid is a next-generation cryolipolysis device for targeted fat reduction using controlled cold. Managed by the USER ASSIST® Artificial Intelligence, the system analyzes fat volume, density and composition in real time and automatically adjusts cryolipolysis parameters to the patient’s morphology. Patented OvoID Cryodes® deliver homogeneous suction and improved cold distribution across the treatment area. The device requires no consumables, enables simultaneous treatments and supports free-hands sessions.

USER ASSIST® (Artificial Intelligence)
USER ASSIST® is an embedded AI that monitors the patient’s tissue during the session: it assesses fat volume, density and composition, cross-references measurements and adapts cooling parameters live to optimize treatment per morphology. Interactive adaptation aims to increase consistency of outcomes.

OvoID Cryodes® — Safety and efficiency
The ovoid-shaped OvoID Cryodes® are patented and engineered to provide uniform suction distribution through a striated, curved contact surface, increasing patient comfort during and after treatment. The system’s patented cooling architecture uses twice the number of thermal extractors compared with typical devices, improving thermal homogeneity across the treated area.

Treatment principles & patient experience
Cryolipolysis targets adipocytes sensitive to cold: controlled cold exposure crystallizes intracellular triglycerides and triggers progressive elimination of fat cells. Initial visible results commonly appear around 3 weeks post-treatment; slimming progresses over 2–3 months before stabilizing. The procedure is non-invasive and generally well tolerated, allowing patients to maintain normal activities. Complementary measures (regular exercise, balanced nutrition, hydration) help maximize outcomes.

Clinical results & evidence
Most published studies on cryolipolysis report average fat reduction of 15%–25% per session. Clinical data cited for the CryoSlim® Hybrid indicate higher averages of 29%–39% fat elimination per session (study by Henri Mondor Hospital, Créteil). Reported patient metrics include a 93% satisfaction rate and a 90% recommendation rate. A prospective study on saddlebags (53 patients) is referenced.

Main clinical results

• 29%–39% fat elimination per session (reported)
• 93% patient satisfaction (reported)
• 90% patient recommendation rate (reported)
• No pain reported by patients (reported)

Indications
Treatment of localized fat deposits (love handles, saddlebags, gluteal region, etc.); non‑invasive alternative to liposuction for localized slimming.

Warranty
The CryoSlim® Hybrid includes a 2-year manufacturer warranty.

Technical specifications

• Commercial model: CryoSlim® Hybrid
• Brand / manufacturer: AAMS (Anti Aging Medical Systems)
• Technology: Cryolipolysis with patented OvoID Cryodes®
• Pilot system: USER ASSIST® Artificial Intelligence for live parameter adaptation
• Reported clinical effectiveness: 29%–39% fat reduction per session (study cited)
• Reported patient satisfaction: 93% satisfied; 90% recommend
• Treatment features: no consumables required; simultaneous treatments; free-hands sessions
• Patient experience: non-invasive, generally painless
• Result timeline: first visible results ~3 weeks; ongoing improvement 2–3 months
• Cooling system: patented architecture with twice the number of thermal extractors for improved cold homogeneity
• Warranty: 2 years manufacturer warranty
• Reference study: Adjadj L., SidAhmed-Mezi M., Mondoloni M., Meningaud JP., Hersant B. Assessment of the Efficacy of Cryolipolysis on Saddlebags: A Prospective Study of 53 Patients. Plast Reconstr Surg. 2017 Jul;140(1):50-57 (cited)